OWC Pharmaceuticals Rese... (PK) Stock Price - OWCP

0.011
0.00 (0.0%)
0.011
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
OWC Pharmaceuticals Research Corporation (PK) OWCP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.011 0.00 0.00 0.00 0.011 08:30:28
Bid Price Ask Price Spread Spread % News
0.011 0.0114 0.0004 3.51% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.011 USD

OWC Pharmaceuticals Rese... (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.49M 407.74M 206.51M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
12.61k $ - 0.00% - -

more financials information »

OWC Pharmaceuticals Rese... (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OWCP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00850.01170.0080250.010344517,451,0650.002529.41%
1 Month0.0150.01530.0080.010007410,565,856-0.004-26.67%
3 Months0.0310.03940.00750.01503919,105,738-0.02-64.52%
6 Months0.00620.15390.0030.03554838,212,6240.004877.42%
1 Year0.02570.15390.0030.03170794,752,472-0.0147-57.2%
3 Years0.65870.850.0030.10413482,230,497-0.6477-98.33%
5 Years0.223.230.0030.21981242,230,618-0.209-95.0%

OWC Pharmaceuticals Rese... (PK) Description

OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis specifically designed for the treatment of several illnesses/medical conditions. Under the direction of Dr. Yehuda Baruch, our Director of Research and Regulatory Affairs and Chief Science Officer, the Company has recently filed a patent application with the United States Patent and Trademark Office for its active cannabinoid-based topical cream. OWC has also entered into an agreement with Mediq Innovation Partners for marketing OWC's topical psoriasis cream in Germany. OWC has also progressed on using specific dosages of its Cannabaniod-based products administered through soluble pills taken orally, with its initial focus on PTSD, multiple myeloma and topical treatment of burns in addition to psoriasis. Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.